Why the study?
Does an ERAS protocol reduce narcotic pain medication usage in patients undergoing primary cleft palate repair?
Does an ERAS protocol reduce narcotic pain medication usage in patients undergoing primary cleft palate repair?
Implementation of ERAS protocols in primary cleft palate repair reduces narcotic usage while maintaining patient and parent satisfaction.
Supports ERAS for lower narcotics in cleft repair without satisfaction loss; hypothesis-generating, needing RCTs before practice change.
The ERAS protocols provide improved inpatient pain management following primary palatoplasty as evidence by decreased total narcotic pain medication usage. The use of multimodality therapy and increased patient education regarding non-narcotic medications can improve the transition of care from inpatient to outpatient, without sacrificing patient/parent satisfaction. The results of this study merit future study into more restricted use of opioid pain medications with greater emphasis on the use of multimodal therapeutics as primary agents as opposed to adjuncts.
No takes yet. Share an insight, caveat, or question.
Moffitt et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: